Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel AMPK activators synthesized at GlaxoSmithKline

Oct. 2, 2012

Japanese researchers disclose new glucokinase activators

Oct. 2, 2012

Daiichi Sankyo divulges new Mdm2/p53 inhibitors

Oct. 2, 2012

GlaxoSmithKline patents new RIP-2 inhibitors

Oct. 2, 2012

Merck KGaA discloses novel agents for cancer

Oct. 2, 2012

Roche presents new antidiabetic compounds

Oct. 1, 2012

Novel BACE1 inhibitors created at Janssen Pharmaceutica

Oct. 1, 2012

New York University presents new PGRN variants for inflammation

Oct. 1, 2012

Novel AMPK activators disclosed in GSK patent

Oct. 1, 2012

Research at the University of Pennsylvania yields new cancer biotherapeutics

Oct. 1, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...